ライフサイエンスコーパス: atrial appendage

1 en the left superior pulmonary vein and left atrial appendage.

2 to the rest of the atria, ending at the left atrial appendage.

3 nantly because of interference from the left atrial appendage.

4 into the distal coronary sinus and the right atrial appendage.

5 was inserted into the incision in the right atrial appendage.

6 e normal pericardial space through the right atrial appendage.

7 oach from a femoral vein to pierce the right atrial appendage.

8 e distal coronary sinus and one in the right atrial appendage.

9 culae and the crista terminalis of the right atrial appendage.

10 Myofibroblasts were not detected in the left atrial appendage.

11 All patients underwent closure of the left atrial appendage.

12 gament disruption, and exclusion of the left atrial appendage.

13 n the posterior left atrium than in the left atrial appendage.

14 y in CV was found between the right and left atrial appendages.

15 HCAs were dissected from right atrial appendages.

16 ime of first AF recurrence at both the right atrial appendage (161+/-22 vs 167+/-26 ms, P=0.05) and d

17 MV leaflets), interatrial septum (84%), left atrial appendage (86%), and left ventricle (77%) was obs

18 NO* concentration was decreased in the left atrial appendage, although NOS expression was not affect

19 Electrodes were positioned in the right atrial appendage and coronary sinus in 13 patients.

20 We measured AFCL at the right atrial appendage and distal coronary sinus before attemp

21 he coronary sinus (CS) cephalad, between the atrial appendage and left pulmonary veins, was dissected

22 s, the anterior part of the septum, the left atrial appendage and the superior vena cava.

23 CACs and CSCs were cultured from left atrial appendages and blood samples obtained from patien

24 of AF, emphasize the importance of the left atrial appendage, and consider challenges and future dir

25 d from the left ventricle (VP, n=29) or left atrial appendage (AP, n=12) to induce CM.

26 premature atrial contractions, from the left atrial appendage at a coupling interval of 200 ms in 7 h

27 cro m, n=71) were dissected from human right atrial appendages at the time of cardiac surgery and can

28 +/-5 microm, n=70) were dissected from right atrial appendages at the time of cardiac surgery and can

29 itional sites including the tip of the right atrial appendage, at the fossa ovalis, and in the distal

30 Biopsies were obtained from the right atrial appendage before and after aortic cross-clamping.

31 of decorin protein core, uncovered in human atrial appendages, can regulate the local bioavailabilit

32 Left atrial appendage closure (LAAC) and nonwarfarin oral ant

33 ught to assess composite data regarding left atrial appendage closure (LAAC) in 2 randomized trials c

34 The risk-benefit ratio of left atrial appendage closure (LAAC) versus systemic therapy

35 Left atrial appendage closure (LAAC) was approved by the U.S.

36 to evaluate the results associated with left atrial appendage closure (LAAC) with the AMPLATZER Cardi

37 l Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) with the Watchman device

38 AF trial who underwent attempted device left atrial appendage closure (n=542 patients) and those from

39 (PROTECT AF) randomized trial compared left atrial appendage closure against warfarin in atrial fibr

40 Safety data on percutaneous left atrial appendage closure arises from centers with consid

41 The implantation of left atrial appendage closure device (WATCHMAN, Boston Scient

42 tack, or thromboembolism) score >/=1, a left atrial appendage closure device is noninferior to long-t

43 dated overview of current transcatheter left atrial appendage closure devices and review the results

44 Over the past decade, percutaneous left atrial appendage closure has emerged as a valid alternat

45 ular AF at risk for stroke treated with left atrial appendage closure have favorable QOL changes at 1

46 e outcomes associated with percutaneous left atrial appendage closure is higher in the real-world pop

47 The "local" strategy of left atrial appendage closure is noninferior to "systemic" an

48 erse outcomes and costs of percutaneous left atrial appendage closure procedure in the US.

49 , including radiofrequency ablation and left atrial appendage closure procedures for patients with AF

50 Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology [ASAP]; NCT00851578)

51 In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protecti

52 ucted to determine whether percutaneous left atrial appendage closure with a filter device (Watchman)

53 t improvement in the safety of Watchman left atrial appendage closure with increased operator experie

54 Left atrial appendage closure with the device (n = 463) or wa

55 and review the results associated with left atrial appendage closure, focusing on procedural and lat

56 During left atrial appendage closure, the estimated dose absorbed by

57 xperience on the safety of percutaneous left atrial appendage closure.

58 In the study, we performed left atrial appendage closure.

59 profound and of longer duration for the left atrial appendage compared with the left atrium as a whol

60 This study compared left atrial and left atrial appendage contraction velocities in sinus rhythm

61 In patients, left atrial appendage contraction velocities measured during

62 Peak left atrial appendage contraction velocities were significant

63 on at all time intervals as assessed by left atrial appendage contraction velocity (LAACV) was signif

64 ld (DFT) testing was performed using a right atrial appendage/coronary sinus lead configuration in 38

65 nscatheter aortic valve replacement and left atrial appendage device occlusion, is being increasingly

66 ardiac myocytes were isolated from the right atrial appendage during CABG.

67 fibrillation are depressed relative to left atrial appendage emptying velocities measured during atr

68 4.9 cm, p < 0.0001 and lower mean peak left atrial appendage emptying velocity (LAAEV), 38 versus 56

69 spontaneous echo contrast, we measured left atrial appendage emptying velocity and calculated shear

70 ntricular diastolic function, and lower left atrial appendage emptying velocity were independently as

71 -determined transmitral diastolic flow, left atrial appendage emptying, and pulmonary venous flow), c

72 vein, ganglionated plexi ablation, and left atrial appendage excision with optional additional lines

73 llow-up continues to support a role for left atrial appendage exclusion from the central circulation

74 atrial fibrillation, left atrial size, left atrial appendage flow velocities and thrombus.

75 s with atrial flutter exhibited greater left atrial appendage flow velocities before cardioversion th

76 After cardioversion, left atrial appendage flow velocities decreased compared with

77 Left atrial appendages from 239 patients stratified by corona

78 Human CPCs from the right atrial appendages from children of different ages underg

79 METHODS AND Human CPCs from the right atrial appendages from children of different ages underg

80 Right-atrial appendages from control sinus rhythm patients or

81 proteins (Kv1.5 and Kv2.1) in left and right atrial appendages from patients (n = 28) in normal sinus

82 In contrast, atrial appendages from patients in persistent atrial fib

83 rbored a cleavage site that was not found in atrial appendages from patients in sinus rhythm.

84 iques and immunoconfocal microscopy in right atrial appendages from patients with ischemic heart dise

85 coproteins were identified in left and right atrial appendages from the same patients.

86 The impaired left atrial appendage function after cardioversion was less p

87 ents with atrial flutter and to compare left atrial appendage function in the pericardioversion perio

88 ibrillation because of better preserved left atrial appendage function.

89 Tissue samples from the atrial appendages had a greater concentration of norepin

90 CSCs were isolated from the right atrial appendage harvested and processed during surgery.

91 In this setting, thrombus in the left atrial appendage has been found to be the source of stro

92 typically results from thrombus in the left atrial appendage has led to the development of mechanica

93 he intramyocardial blood vessels of the left atrial appendage have an increased CML presence and proi

94 ficantly higher in blood vessels of the left atrial appendage in AF patients as compared to controls,

95 has, for the first time, implicated the left atrial appendage in the pathogenesis of stroke in atrial

96 trial fibrillation, suggesting that the left atrial appendage is mechanically "stunned."

97 ssigned to undergo empirical electrical left atrial appendage isolation along with extensive ablation

98 e effectiveness of empirical electrical left atrial appendage isolation for the treatment of LSPAF.

99 (Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcom

100 repeat procedures, empirical electrical left atrial appendage isolation was performed in all patients

101 x coronary artery, and catheters in the left atrial appendage, jugular and carotid vessels.

102 , or by equivalent test pacing from the left atrial appendage (LAA) at 5% or 50% greater than the sin

103 ard for the exclusion of thrombi in the left atrial appendage (LAA) before ablation for atrial fibril

104 This study investigated the left atrial appendage (LAA) by computed tomography (CT) and m

105 as to assess the safety and efficacy of left atrial appendage (LAA) closure in nonvalvular atrial fib

106 o determine which surgical technique of left atrial appendage (LAA) closure is most successful by ass

107 to determine the efficacy and safety of left atrial appendage (LAA) closure via a percutaneous LAA li

108 Randomized trials of left atrial appendage (LAA) closure with the Watchman device

109 e empirical electrical isolation of the left atrial appendage (LAA) could improve success at follow-u

110 incidence of incomplete ligation of the left atrial appendage (LAA) during mitral valve surgery.

111 Left atrial appendage (LAA) electric isolation is reported to

112 term effect of a brief episode of AF on left atrial appendage (LAA) emptying velocity is unknown.

113 haracterization of left atrial (LA) and left atrial appendage (LAA) flow dynamics in patients with at

114 The left atrial appendage (LAA) has been identified as a predomin

115 The left atrial appendage (LAA) is an underestimated site of init

116 Prophylactic exclusion of the left atrial appendage (LAA) is often performed during cardiac

117 The left atrial appendage (LAA) is the source of the vast majorit

118 Electric left atrial appendage (LAA) isolation (LAAI) may occur during

119 Transcatheter left atrial appendage (LAA) ligation may represent an alterna

120 Left atrial appendage (LAA) ligation with the Lariat device i

121 Percutaneous left atrial appendage (LAA) occlusion and novel pharmacologic

122 nonvalvular atrial fibrillation (NVAF), left atrial appendage (LAA) occlusion was noninferior to warf

123 Left atrial appendage (LAA) procedures have been developed to

124 uency and clinical impact of incomplete left atrial appendage (LAA) sealing and consequent peri-devic

125 a CHADS(2) score with left atrial (LA)/left atrial appendage (LAA) spontaneous echo contrast, sludge

126 stroke is thought to be associated with left atrial appendage (LAA) thrombi.

127 e due almost exclusively to emboli from left atrial appendage (LAA) thrombi.

128 The left atrial appendage (LAA) was snap-frozen in situ after pac

129 modality of choice for visualizing the left atrial appendage (LAA).

130 crometers; n=120) dissected from human right atrial appendages (n=78) were cannulated at a distending

131 We evaluated left atrial appendage obliteration in high-risk patients with

132 myofibers prepared from samples of the right atrial appendage obtained from nondiabetic (n = 13) and

133 HCRAs were dissected from right atrial appendages obtained from patients during cardiac

134 pare miR-21 levels in isolated myocytes from atrial appendages obtained from patients in sinus rhythm

135 ere novel oral anticoagulants, Watchman left atrial appendage occlusion device (DEVICE), and warfarin

136 roke, site-specific therapy directed at left atrial appendage occlusion has been now studied for stro

137 after cardioversion, and techniques of left atrial appendage occlusion.

138 s from rat left ventricle and from the right atrial appendage of patients undergoing elective cardiac

139 osis on conduction velocity (CV) in the left atrial appendage of patients with AF.

140 e performed on DNA from lymphocytes and left atrial appendages of 34 patients (25 with AF).

141 uced by > 50% in both the left and the right atrial appendages of AF patients.

142 ed to study conduction in the right and left atrial appendages of isolated Langendorff-perfused murin

143 The atrial appendages of patients undergoing coronary artery

144 Myostatin expression was decreased in atrial appendages of patients with persistent atrial fib

145 n using differential coronary sinus and left atrial appendage pacing techniques encounters a pitfall,

146 k using differential coronary sinus and left atrial appendage pacing techniques in patients with left

147 eous echo contrast (RR 3.7, p < 0.001), left atrial appendage peak flow velocities < or = 20 cm/s (RR

148 The percutaneous approach via the right atrial appendage provides a rapid, safe route to access

149 Electrodes were positioned in the right atrial appendage (RA), left subclavian vein (LSV), proxi

150 s of a shock between electrodes in the right atrial appendage (RAA) and coronary sinus (CS).

151 ir enzymatic sources in samples of the right atrial appendage (RAA) from 303 patients undergoing card

152 and isolated atrial myocytes from the right atrial appendage (RAA) of patients undergoing cardiac su

153 gy of the standard lead configuration, right atrial appendage (RAA) to coronary sinus (CS), was reduc

154 tion electrodes were positioned in the right atrial appendage (RAap), distal coronary sinus (DCS), pr

155 NAs were highly correlated in 233 human left atrial appendage samples.

156 Left atrial appendage shear rates were also higher in patient

157 Left atrial appendage stunning also occurs in patients with a

158 Left atrial appendage stunning has recently been proposed as

159 This study sought to determine whether left atrial appendage stunning occurs in patients with atrial

160 The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patien

161 follow-up from the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patien

162 predominantly from PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patien

163 The PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patien

164 multicenter PROTECT AF study (Watchman Left Atrial Appendage System for Embolic Protection in Patien

165 The Watchman Left Atrial Appendage System for Embolic Protection in Patien

166 olic function and regional left atrial (left atrial appendage) systolic function upon resumption of s

167 , as well as the pericardium, right and left atrial appendages, the junction of the right atrium and

168 onferring moderate risk) more frequently had atrial appendage thrombi (RR 2.6, p < 0.001) and reduced

169 Warfarin inhibits formation of atrial appendage thrombi and markedly reduces cardioembo

170 Left atrial appendage thrombosis and embolization is the prin

171 Patients without atrial cavity thrombus or atrial appendage thrombus by TEE are cardioverted on ach

172 ng thrombosis may contribute to formation of atrial appendage thrombus, but these conditions remain i

173 serted after induction of GA to exclude left atrial appendage thrombus, define cardiac function, and

174 utine cardiac surgical procedures from right atrial appendage tissue discarded from 2 age groups: neo

175 Left atrial appendage tissue from 33 AF patients and 9 contro

176 Right atrial appendage tissue was collected from 34 patients,

177 Human atrial appendage tissues from matched cohorts in sinus r

178 Three of these were right atrial appendage-to-right ventricle APs, and epicardial

179 to evaluate the effects of percutaneous left atrial appendage transcatheter occlusion (PLAATO) on the

180 HA functional class, ejection fraction, left atrial appendage velocity, and medications in patients w

181 Cx40 in one allele (Cx40+/-) included bifid atrial appendage, ventricular septal defect, tetralogy o

182 ollow-up of Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention

183 PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention

184 PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention

185 PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention

186 annulus along the posterior base of the left atrial appendage visualized by selective angiography.

187 Right atrial appendage was collected from 8 male patients pre

188 ricuspid valve, interatrial septum, and left atrial appendage were obtained, followed by a left ventr

189 is, the distal coronary sinus, and the right atrial appendage were outside the circuit.

190 Arterioles dissected from right atrial appendage were studied with video microscopy, mem

191 ulmonary bypass, paired samples of the right atrial appendages were obtained before venous cannulatio

192 Thirty-five left atrial appendages were obtained during AF surgery.

193 Methods and Results-- Right atrial appendages were obtained from AF patients undergo

194 erved at the left atrial sites and the right atrial appendage, whereas disorganized atrial electrogra

195 l parameters of the left atrium and the left atrial appendage which have been shown to be associated

196 CVL was higher in left atrial appendages with thick compared with thin intersti

197 tropy in the posterior left atrium than left atrial appendage, with the decrease in Shannon entropy c

198 ved an adequate seal of the neck of the left atrial appendage without significant effect on the struc

199 othesized that partial clipping of the right atrial appendage would increase the blood flow to the le